Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.36
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,335.10
    -7.00 (-0.30%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,349.63
    -259.17 (-0.48%)
     
  • CMC Crypto 200

    1,427.85
    +13.09 (+0.93%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Why Editas Medicine Fell 7.8% on Monday

Why Editas Medicine Fell 7.8% on Monday

Editas Medicine (EDIT) is a pharmaceutical company focused on developing therapies based on CRISPR-CAS9 gene editing technology. On June 11, EDIT stock fell ~7.8% to close at $36.15 over concerns that CRISPR CAS-9 Gene Therapy causes cancer.